Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

OBJECTIVE: The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly by observational studies and expert opinion. Further complicating trials in LVV is the absence of validated a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Rheumatol
Egile Nagusiak: Aydin, Sibel Zehra, Direskeneli, Haner, Sreih, Antoine, Alibaz-Oner, Fatma, Gul, Ahmet, Kamali, Sevil, Hatemi, Gulen, Kermani, Tanaz, Mackie, Sarah L., Mahr, Alfred, Meara, Alexa, Milman, Nataliya, Nugent, Heidi, Robson, Joanna, Tomasson, Gunnar, Merkel, Peter A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668221/
https://ncbi.nlm.nih.gov/pubmed/26077399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.141144
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak